Trial
NCT04128176
Efficacy and Safety of Rituximab Combined With Omalizumab in Patients With Bullous Pemphigoid
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of California, Davis
Collaborators
—
Condition
Bullous Pemphigoid
Intervention
Rituximab combined with Omalizumab
Why stopped
PI did not pursue this study; this study was not IRB-approved and never started.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-07-03